TP73 and non-small cell lung carcinoma: The median values for TP73‐AS1 and CRNDE levels in plasma samples were applied to divide patients with NSCLC into high‐ and low‐expression groups, and the difference in TFS between the two groups was analyzed using the log‐rank test.